MIRVASO: 416 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
416
Total FAERS Reports
1 (0.2%)
Deaths Reported
3
Hospitalizations
416
As Primary/Secondary Suspect
5
Disabilities
First Report: 20120131 · Latest Report: 20140626
What Are the Most Common MIRVASO Side Effects?
#1 Most Reported
Erythema
260 reports (62.5%)
#2 Most Reported
Condition aggravated
190 reports (45.7%)
#3 Most Reported
Flushing
161 reports (38.7%)
All MIRVASO Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Erythema | 260 | 62.5% | 0 | 2 |
| Condition aggravated | 190 | 45.7% | 1 | 1 |
| Flushing | 161 | 38.7% | 0 | 1 |
| Skin burning sensation | 114 | 27.4% | 0 | 1 |
| Feeling hot | 93 | 22.4% | 0 | 0 |
| Rebound effect | 89 | 21.4% | 0 | 0 |
| Off label use | 81 | 19.5% | 1 | 0 |
| Rash macular | 47 | 11.3% | 0 | 0 |
| Pain of skin | 43 | 10.3% | 0 | 0 |
| Drug ineffective | 38 | 9.1% | 0 | 0 |
| Inappropriate schedule of drug administration | 31 | 7.5% | 0 | 0 |
| Skin warm | 31 | 7.5% | 0 | 0 |
| Pruritus | 28 | 6.7% | 0 | 0 |
| Pallor | 25 | 6.0% | 0 | 0 |
| Drug effect decreased | 24 | 5.8% | 0 | 0 |
| Rash erythematous | 24 | 5.8% | 0 | 0 |
| Swelling face | 22 | 5.3% | 0 | 0 |
| Dermatitis | 21 | 5.1% | 0 | 0 |
| Skin irritation | 21 | 5.1% | 1 | 0 |
| Rosacea | 19 | 4.6% | 0 | 0 |
Who Reports MIRVASO Side Effects? Age & Gender Data
Average age: 47.9 years. Most reports from: US. View detailed demographics →
Is MIRVASO Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 0 | 0 |
| 2013 | 161 | 1 | 1 |
| 2014 | 179 | 0 | 2 |
What Is MIRVASO Used For?
MIRVASO vs Alternatives: Which Is Safer?
MIRVASO vs MISOPROSTOL
MIRVASO vs MOMETASONE
MIRVASO vs MOMETASONE FUROATE
MIRVASO vs MONTELUKAST
MIRVASO vs MORPHINE
MIRVASO vs MOXIFLOXACIN
MIRVASO vs MUPIROCIN
MIRVASO vs MUPIROCIN\MUPIROCIN
MIRVASO vs MYCOPHENOLATE MOFETIL
MIRVASO vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
Official FDA Label for MIRVASO
Official prescribing information from the FDA-approved drug label.